128 related articles for article (PubMed ID: 27444415)
21. TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study.
Kamiza AB; Hsieh LL; Tang R; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; You JF; Wang WC; Hsiung CA; Yeh CC
PLoS One; 2016; 11(12):e0167354. PubMed ID: 27907203
[TBL] [Abstract][Full Text] [Related]
22. Functional polymorphisms in the promoter region of miR-17-92 cluster are associated with a decreased risk of colorectal cancer.
Sun R; Liang Y; Yuan F; Nie X; Sun H; Wang Y; Yu T; Gao L; Zhang L
Oncotarget; 2017 Oct; 8(47):82531-82540. PubMed ID: 29137282
[TBL] [Abstract][Full Text] [Related]
23. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.
Xu X; Chen R; Li Z; Huang N; Wu X; Li S; Li Y; Wu S
BMC Cancer; 2015 Dec; 15():1023. PubMed ID: 26714817
[TBL] [Abstract][Full Text] [Related]
25. Dysregulation of MicroRNA-543 expression in colorectal cancer promotes tumor migration and invasion.
Sun J; Zhou J; Dong M; Sheng W
Mol Carcinog; 2017 Jan; 56(1):250-257. PubMed ID: 27148794
[TBL] [Abstract][Full Text] [Related]
26. Impact of Genetic Variation in MicroRNA-binding Site on Susceptibility to Colorectal Cancer.
Kang BW; Jeon HS; Chae YS; Lee SJ; Park JS; Choi GS; Kim JG
Anticancer Res; 2016 Jul; 36(7):3353-61. PubMed ID: 27354594
[TBL] [Abstract][Full Text] [Related]
27. 3'-UTR Polymorphisms in the MiRNA Machinery Genes DROSHA, DICER1, RAN, and XPO5 Are Associated with Colorectal Cancer Risk in a Korean Population.
Cho SH; Ko JJ; Kim JO; Jeon YJ; Yoo JK; Oh J; Oh D; Kim JW; Kim NK
PLoS One; 2015; 10(7):e0131125. PubMed ID: 26147304
[TBL] [Abstract][Full Text] [Related]
28. SNPs in microRNA-binding sites in the ITGB1 and ITGB3 3'-UTR increase colorectal cancer risk.
Ye P; Li Z; Jiang H; Liu T
Cell Biochem Biophys; 2014 Sep; 70(1):601-7. PubMed ID: 24777809
[TBL] [Abstract][Full Text] [Related]
29. Association between functional polymorphisms in the promoter of the miR-143/145 cluster and risk of conotruncal heart defects.
Wen H; Zhang R; Li Y; Qian H; Yan Z; Chen Y; Li G
Per Med; 2019 Nov; 16(6):449-455. PubMed ID: 31691635
[No Abstract] [Full Text] [Related]
30. Meta-analysis of the association between a polymorphism in microRNA-196a2 and susceptibility to colorectal cancer.
Shi KQ; Lin Z; Li DW; Fang YX; Gao J; Deng ZJ; Chen L; Li GL; Wu JM; Tang KF
Onkologie; 2013; 36(10):560-5. PubMed ID: 24107909
[TBL] [Abstract][Full Text] [Related]
31. MiR-382 inhibits cell growth and invasion by targeting NR2F2 in colorectal cancer.
Zhou B; Song J; Han T; Huang M; Jiang H; Qiao H; Shi J; Wang Y
Mol Carcinog; 2016 Dec; 55(12):2260-2267. PubMed ID: 26800338
[TBL] [Abstract][Full Text] [Related]
32. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.
Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L
Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844
[TBL] [Abstract][Full Text] [Related]
33. Susceptibility to Colorectal Cancer and Two Genetic Polymorphisms of XRCC4.
Emami N; Saadat I; Omidvari S
Pathol Oncol Res; 2015 Sep; 21(4):881-5. PubMed ID: 25662981
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-217 functions as a prognosis predictor and inhibits colorectal cancer cell proliferation and invasion via an AEG-1 dependent mechanism.
Wang B; Shen ZL; Jiang KW; Zhao G; Wang CY; Yan YC; Yang Y; Zhang JZ; Shen C; Gao ZD; Ye YJ; Wang S
BMC Cancer; 2015 May; 15():437. PubMed ID: 26016795
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-544a Regulates Migration and Invasion in Colorectal Cancer Cells via Regulation of Homeobox A10.
Sun S; Su C; Zhu Y; Li H; Liu N; Xu T; Sun C; Lv Y
Dig Dis Sci; 2016 Sep; 61(9):2535-44. PubMed ID: 27165435
[TBL] [Abstract][Full Text] [Related]
36. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
[TBL] [Abstract][Full Text] [Related]
37. Association of polymorphisms in microRNA-binding sites and colorectal cancer in an Iranian population.
Azimzadeh P; Romani S; Mohebbi SR; Mahmoudi T; Vahedi M; Fatemi SR; Zali N; Zali MR
Cancer Genet; 2012 Oct; 205(10):501-7. PubMed ID: 22939228
[TBL] [Abstract][Full Text] [Related]
38. miR-19-5p Enhances Tumorigenesis in Human Colorectal Cancer Cells by Targeting TSPYL5.
Huang C; Luo H
DNA Cell Biol; 2018 Jan; 37(1):23-30. PubMed ID: 29240449
[TBL] [Abstract][Full Text] [Related]
39. Association of Arg72Pro of P53 polymorphism with colorectal cancer susceptibility risk in Malaysian population.
Aizat AA; Shahpudin SN; Mustapha MA; Zakaria Z; Sidek AS; Abu Hassan MR; Ankathil R
Asian Pac J Cancer Prev; 2011; 12(11):2909-13. PubMed ID: 22393962
[TBL] [Abstract][Full Text] [Related]
40. Angiopoietin-like protein 2 negatively regulated by microRNA-25 contributes to the malignant progression of colorectal cancer.
Zhou J; Wang J; Wu S; Zhu S; Wang S; Zhou H; Tian X; Tang N; Nie S
Int J Mol Med; 2014 Nov; 34(5):1286-92. PubMed ID: 25174582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
